MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 364 filers reported holding MEDIVATION INC in Q1 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,431,000 | +35.0% | 17,580 | 0.0% | 0.62% | +24.6% |
Q2 2016 | $1,060,000 | -38.3% | 17,580 | -52.9% | 0.50% | -39.5% |
Q1 2016 | $1,718,000 | +246.4% | 37,360 | +264.1% | 0.82% | +246.0% |
Q4 2015 | $496,000 | +13.8% | 10,260 | 0.0% | 0.24% | +7.2% |
Q3 2015 | $436,000 | – | 10,260 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |